169 related articles for article (PubMed ID: 33523209)
1. Intraoperative Mass Spectrometry Platform for IDH Mutation Status Prediction, Glioma Diagnosis, and Estimation of Tumor Cell Infiltration.
Brown HM; Alfaro CM; Pirro V; Dey M; Hattab EM; Cohen-Gadol AA; Cooks RG
J Appl Lab Med; 2021 Jul; 6(4):902-916. PubMed ID: 33523209
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative assessment of isocitrate dehydrogenase mutation status in human gliomas using desorption electrospray ionization-mass spectrometry.
Alfaro CM; Pirro V; Keating MF; Hattab EM; Cooks RG; Cohen-Gadol AA
J Neurosurg; 2019 Jan; 132(1):180-187. PubMed ID: 30611146
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative assessment of tumor margins during glioma resection by desorption electrospray ionization-mass spectrometry.
Pirro V; Alfaro CM; Jarmusch AK; Hattab EM; Cohen-Gadol AA; Cooks RG
Proc Natl Acad Sci U S A; 2017 Jun; 114(26):6700-6705. PubMed ID: 28607048
[TBL] [Abstract][Full Text] [Related]
4. Rapid detection of IDH mutations in gliomas by intraoperative mass spectrometry.
Hua W; Zhang W; Brown H; Wu J; Fang X; Shahi M; Chen R; Zhang H; Jiao B; Wang N; Xu H; Fu M; Wang X; Zhang J; Zhang X; Wang Q; Zhu W; Ye D; Garcia DM; Chaichana K; Cooks RG; Ouyang Z; Mao Y; Quinones-Hinojosa A
Proc Natl Acad Sci U S A; 2024 Jun; 121(23):e2318843121. PubMed ID: 38805277
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative detection of isocitrate dehydrogenase mutations in human gliomas using a miniature mass spectrometer.
Brown HM; Pu F; Dey M; Miller J; Shah MV; Shapiro SA; Ouyang Z; Cohen-Gadol AA; Cooks RG
Anal Bioanal Chem; 2019 Dec; 411(30):7929-7933. PubMed ID: 31754769
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of mutation in isocitrate dehydrogenase 1 and 2 genes using mass spectrometry.
Kanamori M; Maekawa M; Shibahara I; Saito R; Chonan M; Shimada M; Sonoda Y; Kumabe T; Watanabe M; Mano N; Tominaga T
Brain Tumor Pathol; 2018 Apr; 35(2):90-96. PubMed ID: 29671246
[TBL] [Abstract][Full Text] [Related]
7. Rapid determination of isocitrate dehydrogenase mutation status of human gliomas by extraction nanoelectrospray using a miniature mass spectrometer.
Pu F; Alfaro CM; Pirro V; Xie Z; Ouyang Z; Cooks RG
Anal Bioanal Chem; 2019 Mar; 411(8):1503-1508. PubMed ID: 30710208
[TBL] [Abstract][Full Text] [Related]
8. Method for the Intraoperative Detection of IDH Mutation in Gliomas with Differential Mobility Spectrometry.
Haapala I; Kondratev A; Roine A; Mäkelä M; Kontunen A; Karjalainen M; Laakso A; Koroknay-Pál P; Nordfors K; Haapasalo H; Oksala N; Vehkaoja A; Haapasalo J
Curr Oncol; 2022 May; 29(5):3252-3258. PubMed ID: 35621655
[TBL] [Abstract][Full Text] [Related]
9. Metabolic profiles of human brain parenchyma and glioma for rapid tissue diagnosis by targeted desorption electrospray ionization mass spectrometry.
Chen R; Brown HM; Cooks RG
Anal Bioanal Chem; 2021 Oct; 413(25):6213-6224. PubMed ID: 34373931
[TBL] [Abstract][Full Text] [Related]
10. Absolute quantification of 2-hydroxyglutarate on tissue by matrix-assisted laser desorption/ionization mass spectrometry imaging for rapid and precise identification of isocitrate dehydrogenase mutations in human glioma.
Lan C; Li H; Wang L; Zhang J; Wang X; Zhang R; Yuan X; Wu T; Wu J; Lu M; Ma X
Int J Cancer; 2021 Dec; 149(12):2091-2098. PubMed ID: 34224582
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Determination of Isocitrate Dehydrogenase Mutation in Gliomas Using Spectral Editing MRS: A Prospective Study.
Nguyen TB; Melkus G; Taccone M; Moldovan ID; Ghinda D; Gotfrit R; Torres CH; Zakhari N; Chakraborty S; Woulfe J; Jansen G; McInnes MD; Thornhill RE; Cameron I; AlKherayf F
J Magn Reson Imaging; 2021 Feb; 53(2):416-426. PubMed ID: 32940938
[TBL] [Abstract][Full Text] [Related]
12. Comparative Value of 2-Hydroxyglutarate-to-Lipid and Lactate Ratio versus 2-Hydroxyglutarate Concentration on MR Spectroscopic Images for Predicting Isocitrate Dehydrogenase Mutation Status in Gliomas.
Suh CH; Kim HS; Park JE; Jung SC; Choi CG; Woo DC; Lee HB; Kim SJ
Radiol Imaging Cancer; 2020 Jul; 2(4):e190083. PubMed ID: 33778723
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting.
Tietze A; Choi C; Mickey B; Maher EA; Parm Ulhøi B; Sangill R; Lassen-Ramshad Y; Lukacova S; Østergaard L; von Oettingen G
J Neurosurg; 2018 Feb; 128(2):391-398. PubMed ID: 28298040
[TBL] [Abstract][Full Text] [Related]
14. Rethinking extent of resection of contrast-enhancing and non-enhancing tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification.
Park YW; Kim S; Han K; Ahn SS; Moon JH; Kim EH; Kim J; Kang SG; Kim SH; Lee SK; Chang JH
Eur Radiol; 2024 Feb; 34(2):1376-1387. PubMed ID: 37608093
[TBL] [Abstract][Full Text] [Related]
15. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K
J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy and potential covariates for machine learning to identify IDH mutations in glioma patients: evidence from a meta-analysis.
Zhao J; Huang Y; Song Y; Xie D; Hu M; Qiu H; Chu J
Eur Radiol; 2020 Aug; 30(8):4664-4674. PubMed ID: 32193643
[TBL] [Abstract][Full Text] [Related]
17. Tissue 2-Hydroxyglutarate as a Biomarker for
Sim HW; Nejad R; Zhang W; Nassiri F; Mason W; Aldape KD; Zadeh G; Chen EX
Clin Cancer Res; 2019 Jun; 25(11):3366-3373. PubMed ID: 30777876
[TBL] [Abstract][Full Text] [Related]
18. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
Chen SC; Lo CM; Wang SH; Su EC
BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275
[TBL] [Abstract][Full Text] [Related]
19. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF
Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548
[TBL] [Abstract][Full Text] [Related]
20. Tissue 2-Hydroxyglutarate and Preoperative Seizures in Patients With Diffuse Gliomas.
Ohno M; Hayashi Y; Aikawa H; Hayashi M; Miyakita Y; Takahashi M; Matsushita Y; Yoshida A; Satomi K; Ichimura K; Hamada A; Narita Y
Neurology; 2021 Nov; 97(21):e2114-e2123. PubMed ID: 34610989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]